Roche’s COVID-19 Antibody Cocktail Launched In India
New Delhi: Roche India and Cipla Limited, in a joint statement on Monday, announced the launch of their Antibody Cocktail -- 'Casirivimab and Imdevimab' for the treatment of mild to moderate COVID-19 in patients in India.
The cocktail…